DR. JOHN T. SANDLUND, MD

Plain English
This study looked at the motor skills of adults diagnosed with attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) to see how they compared to typical standards. It involved 153 adults and found that most had significantly poorer motor skills than expected, especially in areas like body coordination, with the ASD group showing the most difficulties. This matters because it highlights the need for doctors to evaluate motor skills in adults with these conditions, as it can help in understanding their challenges better. Who this helps: This helps patients with ADHD and ASD, as well as their healthcare providers.

Plain English
This study looked at whether face masks help protect children from COVID-19 and other respiratory infections. The researchers found that there is no strong evidence showing that masks reduce the spread of these viruses among kids. They also noted several negative effects of masking, such as difficulties in communication, learning, and physical discomfort. Who this helps: This information is important for parents and educators making decisions about mask use for children.

Plain English
This study looked at a type of childhood cancer called ALK-positive anaplastic large cell lymphoma (ALK+ ALCL), which is common in kids. The researchers analyzed samples from 46 patients and found that, on average, each sample contained 25 genetic changes, indicating a lot of variability among these cancers. They discovered two main groups of ALK+ ALCL: one with lower ALK levels that seems to be more related to immune system responses, and another with higher ALK levels linked to cell growth and metabolism, which could impact treatment strategies and outcomes. Who this helps: This information benefits doctors and researchers working on treatments for pediatric lymphoma patients.

Plain English
This study looked at how accurately two different types of activity monitors, one worn on the wrist and the other on the hip, track the physical activity levels of 3-year-old children. Researchers tested thirty kids while they performed various activities, finding that wrist monitors were more sensitive than hip ones, yielding a very high accuracy rate for identifying active vs. inactive states. This research is important because it helps establish clearer guidelines for measuring and understanding how much physical activity preschoolers are getting, which can be used to encourage healthier lifestyles among young children. Who this helps: This helps parents and caregivers of preschoolers by providing better tools to monitor and promote their children's physical activity.

Plain English
This study looked at the effectiveness of mask mandates for children during the COVID-19 pandemic by reviewing various research studies. Out of 597 studies examined, only 22 were included in the analysis, and none provided strong evidence that masks effectively reduced COVID-19 infections in children. The majority of studies either found no clear benefits to wearing masks or had serious issues that made their results unreliable. Who this helps: This information helps policymakers, educators, and parents make informed decisions about mask-wearing for children.

Plain English
This study looked at a type of cancer called anaplastic large cell lymphoma (ALCL), which affects children and is linked to a specific genetic change involving the anaplastic lymphoma kinase (ALK). Researchers examined 46 cases and found that the tumors could be divided into two groups based on their ALK levels: one with low ALK expression that was linked to immune responses, and another with high ALK expression that was associated with more aggressive growth patterns. Understanding these differences helps doctors tailor treatments and predict outcomes for children with this type of lymphoma. Who this helps: This helps patients with pediatric ALK-positive ALCL and their doctors by providing insights for better treatment options.

Plain English
The study focused on how midwives and diabetes nurses manage screening and care for women with gestational diabetes. Researchers interviewed 18 healthcare professionals and found that while women were very motivated to stay healthy during pregnancy, many did not follow up on care after giving birth. Only a few continued with long-term support, mainly because they felt healthy and were focusing on their babies, which highlights a need for better resources and teamwork in post-delivery care. Who this helps: This helps women with a history of gestational diabetes by improving their ongoing care.

Plain English
This study looked at how much exercise and sitting time pregnant women in Sweden engage in and how these factors affect their health and the health of their babies. It found that only 27.3% of the women met the recommended activity level, and those who exercised more had better outcomes, such as a lower chance of needing an emergency cesarean section and healthier weight gain. On the other hand, spending more time sitting was linked to poorer health ratings during pregnancy. Who this helps: This research helps pregnant women by highlighting the importance of staying active for better health.

Plain English
Researchers created a smartphone app called MyBalance to help older adults check their balance and leg strength independently, potentially reducing falls. They tested this app against standard clinical assessments with 31 older adults and found that the app's leg strength measurement closely matched clinical tests, showing a strong correlation. However, the app's balance tests only had a few moderate correlations with clinical measures, indicating that more work is needed to improve its effectiveness. Who this helps: This benefits older adults who want to monitor their balance and strength at home.

Plain English
This study looked at a new test called the Clarity assay, which is designed to detect harmful toxins from a bacteria called Clostridioides difficile (C. diff) in stool samples. The researchers found that Clarity correctly identified 96.2% of negative cases and 100% of positive cases when compared to the standard testing methods. This is important because having a reliable and quick test for C. diff can help diagnose infections more effectively, which can improve patient outcomes. Who this helps: Patients suspected of having C. difficile infections.

Plain English
This study looked at different tests for Clostridioides difficile infection (CDI) and how they performed in diagnosing patients. Researchers found that the PCR test was the most sensitive (100%) and the Quik Chek test was the most specific (100%). They also discovered that patients with toxin-positive results tended to have more severe clinical factors, like higher white blood cell counts, previous antibiotic use, and more hospital stays, which can help doctors diagnose CDI more reliably. Who this helps: This research helps doctors and healthcare providers in diagnosing and treating patients with CDI.

Plain English
This study looked at a new type of sensitive test for detecting Clostridioides difficile, which causes serious gut infections. The researchers found that these ultrasensitive tests can pick up toxins at much lower levels than standard tests, potentially leading to more accurate diagnoses. This matters because accurate testing can help doctors correctly identify infections and treat patients more effectively, which can prevent complications. Who this helps: This helps patients suffering from Clostridioides difficile infections and their doctors.

Plain English
Researchers studied how certain bacteria, called carbapenem-resistant Enterobacteriaceae (CRE), became resistant to treatments from 2013 to 2016 in a healthcare system in Northern California. They found that 39% of the tested bacteria had specific genes making them resistant, and 95% of the samples had identifiable resistance mechanisms. Importantly, two new antibiotics showed high effectiveness against most of these resistant bacteria, which is crucial for treating infections effectively. Who this helps: This benefits patients by providing better options for treating serious infections.

Plain English
This study looked at how well toxin gene tests predict the presence of toxins from the Clostridium difficile bacteria, which causes infections in the gut. The researchers found that relying on these tests alone isn’t very accurate for diagnosing infections, as they often lead to false positives. They suggest using a new, more sensitive test that directly detects toxins in stool samples, which could provide better results. Who this helps: This benefits doctors and patients by improving diagnosis accuracy for Clostridium difficile infections.

Plain English
This study looked at different tests for detecting Clostridioides difficile infections (CDI), comparing a new test called the Clarity assay to standard methods. It found that the Clarity test had a 97% success rate in detecting the toxins and was 100% specific, meaning it correctly identified cases without false positives. In contrast, traditional PCR tests had lower specificity at 79%, and other tests showed even poorer performance, with one method only detecting 58% of cases. This matters because having a reliable and accurate test can lead to better treatment for infections, reducing complications for patients. Who this helps: Patients with Clostridioides difficile infections.

Plain English
This study focused on a new test, the Clarity assay, for detecting toxins from the bacteria Clostridioides difficile in stool samples. The researchers found that the Clarity assay had a high accuracy for confirming infections, achieving 96.3% agreement with the standard test after further analysis of samples with mixed results. This is significant because it shows that the Clarity test can quickly and accurately diagnose C. difficile infections, which is critical for effective patient treatment. Who this helps: This helps patients suspected of having C. difficile infections by providing a faster and more accurate diagnosis.

Plain English
Researchers studied a new ultrasensitive test for detecting toxins from Clostridioides difficile (C. diff), a common hospital infection. They found that this new test, called the Clarity assay, correctly identified infections 97.4% of the time, compared to 89.0% for the older method. This is important because using the Clarity test can reduce incorrect diagnoses, preventing unnecessary treatments and better managing patient care. Who this helps: This helps patients suspected of having C. diff infections.

Plain English
This study tested a new, affordable method to diagnose tuberculosis (TB) by analyzing specific chemicals in urine. Researchers found that the sensor was fairly effective for people without HIV, correctly identifying TB 78.3% of the time, while its accuracy dropped significantly for those with HIV, with the best performance showing only a 62.3% rate. This matters because a reliable urine test could help identify TB cases, especially in areas where traditional testing methods are challenging. Who this helps: This helps patients, especially those who may have difficulty providing sputum samples, like children or people with respiratory issues.

Plain English
This study tested a new blood test called the Singulex Clarity cTnI assay, which measures a protein called cardiac troponin I that indicates heart damage. The test showed it could detect very low levels of this protein, with a limit of 0.12 ng/L, and it was effective in 96.8% of healthy participants. This is important because it might help doctors identify heart issues earlier and more accurately than current tests. Who this helps: This helps doctors and patients by improving early detection of heart problems.

Plain English
This study evaluated a new test called the Singulex Clarity C. diff toxins A/B assay, which can quickly and accurately detect harmful toxins from the Clostridioides difficile bacteria in stool samples. The new assay was found to have a very high sensitivity of 97.7% and perfect specificity of 100%, meaning it reliably identifies infected patients without falsely identifying healthy ones. This development is important because it can lead to faster and more accurate diagnosis of infections, improving treatment options for patients. Who this helps: This helps patients suffering from C. difficile infections and their doctors.

Plain English
This study looked at how much variation there is in the way people move when doing the same repetitive task, specifically transferring liquid with a pipette. Researchers found that 14 healthy individuals had consistent differences in their movement patterns, both between different people and on different days, suggesting that motor variability is a stable trait. This finding is important because it indicates that some people might be more prone to fatigue or injuries when doing repetitive work, which can help in designing better workplace practices. Who this helps: This helps patients in jobs with repetitive tasks, as well as doctors and workplace health professionals.

Plain English
This study examined the relationship between a protein called HB-EGF and hydrocephalus, which is a condition where fluid builds up in the brain. Researchers found that mice with too much HB-EGF showed higher levels of another protein, VEGF, leading to brain swelling and other related issues. They also observed similar effects in rats, where increasing VEGF caused even more swelling, indicating that too much HB-EGF can drive processes that worsen hydrocephalus. Who this helps: This research helps doctors and researchers understand potential causes of hydrocephalus, which can improve treatment options for affected patients.

Plain English
This research studied a new method for quickly and accurately identifying different types of malaria-causing parasites (Plasmodium species) in human blood. The new test, which uses a technique called real-time PCR, showed very high accuracy, successfully identifying 95.2% of P. falciparum cases and 100% of other Plasmodium species, including P. vivax and P. ovale, in clinical samples. This is important because accurately identifying the species can lead to more effective treatment, especially for those that have dormant stages in the liver which require specific medication. Who this helps: This benefits patients diagnosed with malaria, allowing for better-targeted treatment.

Plain English
This study examined a new test called the Xpert® Ebola Assay, which detects the Ebola virus in blood and saliva samples. It found that the test can accurately identify Ebola with a sensitivity of detecting as low as 73 virus copies per milliliter in lab samples and can detect different strains of the virus without confusing them with non-Ebola infections. This is important because it allows for quick and reliable testing in various settings, especially during outbreaks when rapid diagnosis is crucial. Who this helps: This helps patients at risk of Ebola and healthcare workers responding to outbreaks.

Plain English
This research reports a case where a traveler developed skin lesions after staying in a hotel room that had ticks. This is significant because, while many people are familiar with bedbugs in hotels, this is the first time someone has documented ticks in such a setting. It highlights a new health risk for travelers and raises awareness about the potential for tick infestations in places typically associated with bedbugs. Who this helps: Hotel guests and travelers.

Plain English
This study focused on a type of bacteria called Actinobaculum schaalii, which can cause serious infections in the bloodstream but is often overlooked because it can be outnumbered by other bacteria during testing. Researchers looked at 17 cases where this bacteria was linked to infections, showing that it can invade the body and make patients very ill. The findings highlight the importance of testing for this bacteria in patients who are not improving from urinary infections, as failing to do so could delay proper treatment. Who this helps: This helps patients with urinary tract infections who are not responding to standard treatments.

Plain English
This research explores the role of a protein called VEGF in a condition known as hydrocephalus, where fluid builds up in the brain's ventricles. The study found that higher levels of VEGF can cause the brain's ventricles to enlarge and might influence the development of hydrocephalus in children. Understanding how VEGF works opens the door to developing new non-surgical treatments for hydrocephalus and related brain conditions. Who this helps: This helps patients, especially children with hydrocephalus, and their doctors by providing new treatment options.

Plain English
This study looked at malaria trends over 25 years in a village called Nyamisati in Tanzania. Researchers found that malaria cases dropped significantly: from 70% of people infected in 1985 to just 17.8% in 2010. This decline is important because it indicates that control strategies, including the use of bed nets, are effectively reducing malaria transmission in the region. Who this helps: This helps patients in malaria-affected areas and public health officials working on malaria control.

Plain English
This study examined two proteins, osteopontin (OPN) and parathyroid hormone-related protein (PTHrP), to see how they relate to kidney cancer (renal cell carcinoma or RCC) and patient survival. Researchers analyzed data from 269 patients and found that OPN levels were significantly higher in those with more advanced cancer stages, making it an important indicator for survival in RCC. In contrast, PTHrP did not show any significant prognostic value, suggesting OPN is a better predictor of patient outcomes. Who this helps: This research helps kidney cancer patients by identifying a reliable marker for assessing prognosis.

Plain English
This study looked at travelers with malaria who went to a clinic in Sweden to see if they also had bacterial infections. Out of 755 patients, only 0.3% had harmful bacteria found in their blood, and 4.9% had bacteria from other tests. The findings show that bacterial infections are rare in these patients, suggesting that doctors might not need to give antibiotics as often as previously thought when treating malaria in travelers. Who this helps: This helps doctors making treatment decisions for travelers returning with malaria.

Plain English
This study focused on a molecule called netrin-1, which helps glioblastoma tumors spread and grow new blood vessels, making them harder to treat. Researchers found that netrin-1 boosts tumor cell invasion and blood vessel growth, involving specific pathways including the activation of proteins RhoA and CREB, and an enzyme called cathepsin B. Targeting netrin-1 could improve treatment strategies for people dealing with these aggressive brain tumors. Who this helps: This helps patients with glioblastoma and their doctors seeking better treatment options.

Plain English
This study looked at a substance called VEGF, which is found in higher amounts in the fluid surrounding the brain (CSF) of patients with a condition called hydrocephalus, where too much fluid builds up in the brain's ventricles. Researchers found that increasing VEGF levels in rats led to significant enlargement of the ventricles and changes in brain tissue, supporting the idea that VEGF contributes to hydrocephalus. This finding is important because it suggests that certain drugs that block VEGF could be a new treatment option for patients with hydrocephalus, possibly used alongside surgical methods. Who this helps: This helps patients with hydrocephalus looking for more effective treatment options.

Plain English
This study looked at a protein called soluble carbonic anhydrase IX (CA IX) in patients with kidney cancer, specifically renal cell carcinoma (RCC). Researchers tested the blood of 361 patients and found that those with clear cell RCC had higher levels of CA IX compared to other types of RCC, but CA IX levels did not predict how long patients would survive. The important finding is that while CA IX levels are higher in clear cell RCC, they don't provide useful information about patient prognosis, meaning they can't help doctors determine a patient's outcome. Who this helps: This research benefits doctors and researchers studying kidney cancer.

Plain English
This study looked at a specific molecule, HIF-2alpha, in kidney cancer tissues to see if its levels could help predict patient outcomes. Researchers tested tissue samples from 202 patients and found that HIF-2alpha levels were much higher in a common type of kidney cancer (clear cell RCC) compared to other types, but these levels did not actually help determine how long patients would survive. The key takeaway is that while HIF-2alpha is elevated in certain kidney cancers, the stage of the cancer is a more reliable indicator of a patient's prognosis. Who this helps: This research helps doctors better understand kidney cancer progression and guides them in making treatment decisions.

Plain English
This study looked at how well people with chronic neck pain can reach for visible targets with their arms compared to healthy individuals. Researchers found that both groups with neck pain had less accuracy in their movements, with a consistent difference noted in their arm positioning regardless of movement speed. This matters because it highlights that neck pain not only affects discomfort but also impacts physical functions like reaching and balancing, indicating a need for targeted rehabilitation strategies. Who this helps: Patients with chronic neck pain and their healthcare providers.

Plain English
This study looked at a marker called CD31 in 208 patients with renal cell carcinoma (RCC), which is a type of kidney cancer. Researchers found that CD31 levels were much higher in the most common type of RCC (clear cell) compared to a less common type (papillary), and patients with higher CD31 levels had a better chance of surviving. Specifically, those in the highest quartile of CD31 expression had a significantly more favorable prognosis. Who this helps: This research benefits kidney cancer patients and their doctors by providing insights into tumor characteristics that can inform treatment and prognosis.

Plain English
This study looked at a protein called carbonic anhydrase IX (CA IX) in kidney cancer patients to see how it affects survival chances. They found that patients with a common type of kidney cancer had higher levels of CA IX, and those with low CA IX levels (0-10%) had worse outcomes compared to those with higher levels (11-90% or 91-100%), indicating a clearer risk associated with low CA IX expression. This matters because understanding CA IX levels can help doctors predict how well patients with kidney cancer might do after treatment. Who this helps: This information helps doctors better assess and treat patients with kidney cancer.

Plain English
This study looked at the role of a protein called endoglin (CD105) in kidney cancer, specifically renal cell carcinoma (RCC). Researchers examined tumor samples from 210 patients and found that 75% of the tumors expressed endoglin. Those with higher levels of endoglin had better survival rates, while the protein's expression was lower in more advanced cancer stages, highlighting its potential importance in understanding patient outcomes. Who this helps: This information benefits kidney cancer patients and their doctors.

Plain English
This study looked at how well people with whiplash-related issues can sense the position of their shoulder compared to healthy individuals. Researchers found that the whiplash patients had a significantly lower ability to accurately tell where their shoulder was positioned, and those with poorer shoulder control also reported worse physical function. This matters because understanding the link between shoulder proprioception and physical ability can help improve treatment strategies for these patients. Who this helps: This helps patients with whiplash and their doctors in managing and treating their condition.

Plain English
This study looked at the use of a drug called ifosfamide to treat patients with serious cases of non-Hodgkin's lymphoma that either didn't respond to previous treatments or came back after treatment. In the first trial with 14 patients, 2 people fully recovered, 2 showed partial improvement, and 1 had minimal response, showing ifosfamide can be effective even in tough cases. The second trial involved a combination of ifosfamide with other drugs, producing 4 complete recoveries and 5 partial recoveries among 13 patients, although it also caused significant side effects. Who this helps: This research benefits patients with high-risk non-Hodgkin's lymphoma who have limited treatment options.

Plain English
This study looked at how certain antibodies can stop the growth of Burkitt's lymphoma cells, a type of cancer. Researchers found that these antibodies reduced the activity of two important genes, c-myc and mu, in a specific group of cancer cells with a particular genetic change. In the most sensitive cells, the decrease in these gene activities started just one hour after treatment and led to cell death within three to six hours. Who this helps: This research benefits patients with Burkitt's lymphoma by offering potential new treatment strategies.

Plain English
This study looked at the effectiveness of a drug called ifosfamide in treating 75 young patients with recurring sarcomas and other solid tumors after they had already undergone treatment with another chemotherapy drug called cyclophosphamide. Out of these patients, 24% showed a positive response to ifosfamide, with the best results seen in patients with Ewing's sarcoma, where 45% responded to the treatment. Ifosfamide appeared to be reasonably safe, though some patients experienced low white blood cell counts and hematuria (blood in urine), particularly those without prior pelvic radiation. Who this helps: This helps young patients with relapsed sarcomas and their doctors in finding effective treatment options.